Racial Differences in Medication Utilization for Secondary Prevention of Cardiovascular Disease in Kidney Transplant Recipients: A Post Hoc Analysis of the FAVORIT Trial Cohort-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Racial Differences in Medication Utilization for Secondary Prevention of Cardiovascular Disease in Kidney Transplant Recipients: A Post Hoc Analysis of the FAVORIT Trial Cohort

Published:2022-04 Issue:4 Volume:4 Page:100438
ISSN:2590-0595
Container-title:Kidney Medicine
language:en
Short-container-title:Kidney Medicine

Author:

Fallahzadeh Mohammad Kazem,Ku Elaine,Chu Chi D.,McCulloch Charles E.,Tuot Delphine S.

Funder

National Institute of Diabetes and Digestive and Kidney Diseases

American Society of Nephrology

Publisher

Elsevier BV

Subject

Nephrology,Internal Medicine

Reference34 articles.

1. Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant;Wolfe;N Engl J Med,1999

2. Long-term survival in renal transplant recipients with graft function;Ojo;Kidney Int,2000

3. Patient survival after renal transplantation; more than 25 years follow-up;Arend;Nephrol Dial Transplant,1997

4. Inadequacy of cardiovascular risk factor management in chronic kidney transplantation—evidence from the FAVORIT study;Carpenter;Clin Transplant,2012

5. Cardiovascular disease medications after renal transplantation: results from the Patient Outcomes in Renal Transplantation study;Pilmore;Transplantation,2011

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of timing of administration on lipid-lowering efficacy of statins-meta-analysis;European Journal of Clinical Pharmacology;2023-09-30

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP